Status:
COMPLETED
Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality
Lead Sponsor:
Centers for Disease Control and Prevention
Conditions:
Perinatal Mortality
Stillbirth
Eligibility:
FEMALE
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether a daily prenatal supplement of iron plus folic acid or a daily prenatal supplement with multiple vitamins and minerals given to women from their first...
Detailed Description
In the project area in China, the rate of perinatal mortality (stillbirths and infant deaths within 6 days of birth) is two times that of the United States. Causes of perinatal mortality include, but ...
Eligibility Criteria
Inclusion
- Live in one of the study counties (Laoting, Mancheng, Fengrun, Xianghe, Yuanshi)
- Can follow instructions
- Can swallow pills
Exclusion
- \>= 20 weeks gestation at enrollment
- Previous live birth
- Anemic (hemoglobin \[Hb\] \<10 g/dl in 1st trimester and \< 9.5 g/dl in 2nd trimester) at enrollment
- Current use of iron or other vitamin or mineral supplements (except folic acid)
- Age \< 20 years at enrollment
- Under treatment for anemia at enrollment
- Refuse to participate
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
18962 Patients enrolled
Trial Details
Trial ID
NCT00133744
Start Date
May 1 2006
End Date
December 1 2010
Last Update
March 21 2011
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Fengrun Maternal and Child Health Institute
Fengrun, Hebei, China, 064000
2
Yuanshi Maternal and Child Health Institute
Huaiyang, Hebei, China, 051130
3
Laoting Maternal and Child Health Institute
Laoting, Hebei, China, 063600
4
Mancheng Maternal and Child Health Institute
Mancheng, Hebei, China, 072150